|
524322 Group (X) 16 Sep,09:18
19.46
0.00 (0.00%)
HOW HOT IS THIS STOCK?
Last 15 days data © Rediff.com Add to Watchlist
|
BSE | NSE
 ZoomRefreshDay
Wk
Mn
6Mn
Yr
|
Invest & Trade in on dhan
1 min read
7 hours ago
1 min read
9 hours ago
1 min read
11 hours ago
1 min read
11 hours ago
| Mar ' 26 | Mar ' 25 | Mar ' 24 | Mar ' 23 | Mar ' 22 | |
|---|---|---|---|---|---|
| Sales | 92.74 | - | - | - | - |
| Operating profit | 5.33 | -1.72 | -0.74 | -0.34 | -0.18 |
| Interest | 0.03 | - | - | - | - |
| Gross profit | 5.79 | -1.08 | -0.74 | -0.34 | -0.18 |
| EPS (Rs) | 2.09 | -0.46 | -1.68 | -0.77 | -0.42 |
1 min read
7 hours ago
1 min read
9 hours ago
Q: What is the current share price of Kabra Drugs Ltd.?
A: The current share price of Kabra Drugs Ltd. is ₹ 19.46 (for BSE as on 16 Sep,09:18). The 52-week range is ₹ 35.52 - 15.50. Prices are updated based on live market data.
Q: What is the market capitalization of Kabra Drugs Ltd.?
A: Kabra Drugs Ltd. has a market capitalization of ₹ 46.13 Cr, making it a company.
Q: What is the PE ratio of Kabra Drugs Ltd.?
A: The Price-to-Earnings (PE) ratio of Kabra Drugs Ltd. is 9.30, indicating its valuation relative to earnings.
Q: Is Kabra Drugs Ltd. a good investment?
A: Kabra Drugs Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.
Q: What are the latest financial results of Kabra Drugs Ltd.?
A: Kabra Drugs Ltd. has reported its latest annual results with revenue of ₹ 92.74 and net profit/loss of ₹ 4.96.
